| Issue |
Title |
File |
| No 2 (2012) |
Possibilities of hormonal therapy for diffuse dyshormonal dysplasia of the breast |
(Rus)
|
|
Vysotskaya I.V.
|
| No 2 (2012) |
First report of observation trial about impact of bisphosphonate`s treatment to the quality of life breast cancer patient with bone metastases |
(Rus)
|
|
Zelenova O.V., Bolotina L.V., Nikitina L.Y., Chernikov M.V.
|
| No 1 (2012) |
Basic therapy in the treatment of diffuse fibrocystic mastopathy |
(Rus)
|
|
Vysotskaya I.V.
|
| No 1 (2012) |
Use of progestogel in diffuse forms of mastopathy |
(Rus)
|
|
Meskikh E.V., Rozhkova N.I.
|
| No 4 (2011) |
Drug treatment for metastatic breast cancer |
(Rus)
|
|
Artamonova E.V.
|
| No 4 (2010) |
Target approach to treating osseous system pathology |
(Rus)
|
|
Stenina M.B., Petrova A.D.
|
| No 4 (2010) |
Role of ganaton in antiemetic therapy. New treatment capacities |
(Rus)
|
|
Snegovoy A.V., Manzyuk L.V.
|
| No 4 (2010) |
Hormonal factors of virus-associated cancer of the cervix uteri |
(Rus)
|
|
Churuksayeva O.N., Asadchikova O.N., Kolomiyets L.A., Stukanov S.L., Vidyaeva I.G., Nikitina E.G., Urazova L.N.
|
| No 3 (2010) |
Prevention of bone metastases in breast cancer |
(Rus)
|
|
Kogonia L.M.
|
| No 3 (2010) |
Use of Mastodinon in different forms of mastopathy |
(Rus)
|
|
Rozhkova N.I., Meskikh E.V.
|
| No 3 (2010) |
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer |
(Rus)
|
|
Khokhlova S.V.
|
| No 3 (2010) |
Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients |
(Rus)
|
|
Titova V.A., Kreynina Y.M., Shipilova A.N., Shevchenko L.N., Petrovsky V.Y., Ose I.V., Skobeleva T.F., Akimov A.V., Badmayev A.L.
|
| No 3-4 (2009) |
A COMBINATION OF TAXOTERE, DOXORUBICIN, CYCLOPHOSPHOMIDE IN ADJUVANT CHEMOTHERAPY OF OPERABLE BREAST CANCER GRANULOCYTE COLONY-STIMULATING FACTORS PRIMARY PROPHYLAXIS |
(Rus)
|
|
Besova N.S., Gorbunova V.A., Poddubnaya I.V., Makarenko N.P.
|
| No 3-4 (2009) |
ARTIFICIAL MENOPAUSE AND EXPERIENCE OF CIMICIFUGA EXTRACT USE (KLIMADYNON) |
(Rus)
|
|
Payanidi Y.G., Zhordania K.I.
|
| No 1-2 (2009) |
CURRENT POTENTIALITIES OF THERAPY FOR FIBROCYSTIC DISEASE |
(Rus)
|
|
Vysotskaya I.V.
|
| No 1-2 (2009) |
TAXOTERE: UPDATE (REVIEW OF REPORTS AT THE 31st ANNUAL SYMPOSIUM ON BREAST CANCER (San Antonio, USA) |
(Rus)
|
|
Stenina M.B.
|
| No 1-2 (2009) |
IMPROVEMENT OF OVERALL SURVIVAL WITH PRIMARY BREAST CANCER WITH MICROMESTASES TO THE BONE MARROW BY ADJUVANT CLODRONATE THERAPY |
(Rus)
|
|
Diel I., Jaschke A., Solomayer E.F., Golan S., Bastert G., Sohn S., Schuetz F.
|
| No 1-2 (2009) |
ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY |
(Rus)
|
|
Baum M., Hackshaw A., Houghtona J., Rutqvist L.E., Fornander T., Nordenskjold B., Nicolucci A., Sainsburya R.
|
| No 1-2 (2009) |
ZOMETA IN COMPLEX TREATMENT FOR GENERALIZED BREAST CANCER: A CLINICAL CASE |
(Rus)
|
|
Bolotina L.V.
|
| No 1 (2008) |
ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT |
(Rus)
|
|
Robertson J., Come S., Jones S., Beex L., Kaufmann M., Makris A., Nortier J., Possinger K., Rutqvist L.
|
| No 1 (2008) |
СОВРЕМЕННЫЕ АСПЕКТЫ ПРИМЕНЕНИЯ ТАКСОТЕРА® ПРИ ДИССЕМИНИРОВАННОМ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ |
(Rus)
|
|
., ., .
|
| 1 - 21 of 21 Items |
|
